ラボ開発検査の世界市場

ラボ開発検査の世界市場は2030年までに182億米ドルに達する見込み

2024年に128億米ドルと推定されるラボ開発検査の世界市場は、2024年から2030年にかけてCAGR 6.0%で成長し、2030年には182億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである免疫測定技術は、CAGR 7.7%を記録し、分析期間終了時には51億米ドルに達すると予測されます。血液学・凝固テクノロジー分野の成長率は、分析期間中CAGR 3.9%と推定されます。

米国市場は推定35億米ドル、中国はCAGR9.7%で成長予測

米国のラボ開発検査市場は、2024年に35億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに38億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.8%と5.9%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界のラボ開発検査市場- 主要動向と促進要因のまとめ

なぜラボ開発検査が診断の展望を変えるのか？

ラボ開発検査（LDT）は、複雑で稀な病態に合わせた高度に専門的でカスタマイズ可能な検査ソリューションを提供し、現代診断医学の要となっています。市場に出回る前に規制当局の承認を必要とする市販の体外診断（IVD）検査とは異なり、LDTは個々の検査室で開発・検証されるため、新たな医療ニーズに迅速に対応することができます。この柔軟性により、LDTは個別化医療、腫瘍学、感染症検出、遺伝子スクリーニングに役立っています。早期かつ正確な診断への需要が高まり続ける中、LDTは医学の進歩と患者ケアのギャップを埋める上でますます重要な役割を果たしています。

LDTの採用を促進する重要な要因の一つは、市販の検査では対応できないニッチな診断ニーズに対応できることです。例えば腫瘍学では、LDTは腫瘍プロファイリングに広く使用されており、腫瘍医が個々の患者に特有の遺伝子変異に基づいて治療戦略を調整できるようにしています。ゲノム配列決定技術の急速な進歩は、LDTの関連性をさらに強化し、遺伝性疾患、薬理ゲノム反応、希少遺伝性疾患の同定を可能にしています。さらに、COVID-19のパンデミックは、市販のキットが広く利用される前に多くの検査施設が独自の検査手法を開発したため、新規病原体に迅速に対応するLDTの重要性を浮き彫りにしました。

技術革新はLDTの能力をどのように高めているか？

ラボ開発検査の進化は、分子生物学、人工知能（AI）、自動化の進歩と密接に関連しています。次世代シーケンシング（NGS）とポリメラーゼ連鎖反応（PCR）に基づく技術は、LDTの精度とスピードを大幅に向上させ、疾患感受性と進行に関連する微細な遺伝子変異の検出を可能にしました。AIを駆使したバイオインフォマティクス・ツールはLDTの分析能力をさらに向上させ、大規模なゲノム・データセットにおけるリアルタイムのデータ解釈やパターン認識を可能にしています。こうした技術的飛躍的進歩により、LDTの応用範囲は、腫瘍学や希少疾患診断から感染症サーベイランスやリプロダクティブ・ヘルスまで拡大した。

自動化はまた、LDTの標準化と拡張性においても極めて重要な役割を果たしています。高スループットのロボットシステムは、現在では複雑なアッセイを最小限の人的介入で処理することを容易にし、エラーのリスクを低減して検査室の効率を高めています。クラウドベースのデータストレージとデジタルヘルスプラットフォームの統合によりアクセシビリティが向上し、ヘルスケアプロバイダーが検査結果に遠隔からアクセスして分析し、より多くの情報に基づいた臨床的意思決定を行えるようになりました。さらに、リキッドバイオプシー技術の進歩により、非侵襲的なLDTへの道が開かれ、従来の組織生検の代わりに血液サンプルによるがんの早期発見とモニタリングが可能になりました。このような技術革新は、多様なヘルスケア環境でのLDTの採用を促進し、精密医療におけるLDTの重要性を高めています。

規制の変化はラボ開発検査市場を形成しているか？

LDTは従来、商業的に製造された検査に比べてより柔軟な規制の枠組みの下で運用されてきたが、最近の規制の動向はLDTの開発と採用に影響を与えようとしています。米国では、食品医薬品局（FDA）が検査の正確性、信頼性、患者の安全性を確保するため、LDTに対する監視の強化を検討しています。このため、規制当局、診断検査機関、ヘルスケア利害関係者の間で、技術革新と品質管理のバランスに関する議論が続いています。規制強化は検査施設にさらなるコンプライアンス負担を強いる可能性がある一方で、標準化と透明性を高め、LDTベースの診断薬に対する信頼を高める可能性も秘めています。

世界の規制状況も進化しており、欧州連合（EU）などは体外診断用医薬品規制（IVDR）の枠組みを導入し、LDTに影響を与え、より厳格なバリデーション要件を課しています。このような変化により、多くの検査施設は、進化する規制基準に対応するため、品質管理システム、認定プロセス、臨床バリデーション試験への投資を余儀なくされています。このような課題にもかかわらず、LDTに対する需要は依然として強く、特に規制の柔軟性により新たな病態への迅速な適応が可能な地域では、その傾向が顕著です。規制当局がLDT監視へのアプローチを洗練させる中、検査施設は革新的で価値の高い診断ソリューションを提供する能力を維持しながら、コンプライアンス要件を乗り切る必要があります。

ラボ開発検査市場を促進する主な成長要因は？

ラボ開発検査市場の成長は、複雑な疾患の蔓延、診断技術の進歩、個別化医療に対する需要の高まり、ヘルスケア政策の進化など、いくつかの要因によってもたらされます。主な促進要因の1つは、がん、心血管疾患、遺伝性疾患の負担増であり、これらの疾患には特異性が高く感度の高い診断検査が必要です。LDTは、疾患の早期発見、治療モニタリング、リスク評価のための標的アッセイを開発する柔軟性を提供し、プレシジョン・メディシン・イニシアティブにおいて貴重な存在となっています。ヘルスケアシステムがプロアクティブで予防的なケアモデルへとシフトするにつれ、LDTの需要は増加の一途をたどっています。

市場成長を促進するもう1つの主な要因は、ゲノム・分子検査の拡大です。ゲノムシークエンシングのコストが低下したことで、高度なLDTがより利用しやすくなり、臨床や研究の現場で広く採用されるようになりました。個々の患者にとって最も効果的な治療を決定するのに役立つコンパニオン診断の台頭は、腫瘍学と薬理ゲノミクスにおけるLDTの採用をさらに促進しています。さらに、検査室のワークフローへのAIと機械学習の統合が進むことで、LDTの効率と精度が向上し、ヘルスケアプロバイダーと患者の信頼が高まっています。

分散型検査やポイントオブケア検査が重視されるようになったことも、特にCOVID-19パンデミックへの対応として、LDTの拡大に寄与しています。多くの診断ラボが、緊急の公衆衛生上の要求に応えるために独自の迅速検査ソリューションを開発し、危機的状況におけるLDTの敏捷性を浮き彫りにしました。さらに、遠隔医療やデジタルヘルスプラットフォームの拡大により、遠隔地や在宅での診断ソリューションに対する需要が高まっており、LDTはタイムリーで利用しやすい検査オプションを提供する上で重要な役割を果たしています。

規制の不確実性にもかかわらず、専門的な診断薬に対する需要が高まり続けていることから、ラボ開発検査市場は持続的な成長が見込まれています。精密医療への継続的な投資は、バイオマーカー探索とハイスループットシークエンシングの進歩と相まって、LDTの技術革新をさらに促進すると思われます。検査室が進化する規制状況を乗り切るには、研究機関、ヘルスケアプロバイダー、テクノロジー企業間の協力が、LDTが現代の診断医学の重要な要素であり続けるための鍵となると思われます。

セグメント

技術（免疫測定技術、血液学・凝固技術、分子診断技術、微生物学技術、臨床化学技術、組織学・細胞学技術、フローサイトメトリー技術、質量分析技術、その他技術）、アプリケーション（腫瘍学アプリケーション、遺伝子疾患／遺伝性疾患アプリケーション、感染症／寄生虫疾患アプリケーション、免疫学アプリケーション、内分泌学アプリケーション、栄養／代謝疾患アプリケーション、循環器学アプリケーション、精神／行動障害アプリケーション、小児科特異的検査アプリケーション、血液学／一般血液検査アプリケーション、体液分析アプリケーション、毒物学アプリケーション、その他の疾患アプリケーション）

調査対象企業の例

• 23andMe, Inc.
• Abbott
• Agilent Technologies Inc.
• ARUP Laboratories
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• Guardant Health
• Illumina, Inc.
• Invitae Corporation
• Labcorp
• Mayo Clinic Laboratories
• Myriad Genetics, Inc.
• Natera, Inc.
• NeoGenomics Laboratories
• OPKO Health, Inc.
• QIAGEN
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sonic Healthcare

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Laboratory Developed Tests Market to Reach US$18.2 Billion by 2030

The global market for Laboratory Developed Tests estimated at US$12.8 Billion in the year 2024, is expected to reach US$18.2 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Hematology & Coagulation Technology segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 9.7% CAGR

The Laboratory Developed Tests market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Laboratory Developed Tests Market - Key Trends & Drivers Summarized

Why Are Laboratory Developed Tests Transforming the Diagnostics Landscape?

Laboratory developed tests (LDTs) have become a cornerstone of modern diagnostic medicine, offering highly specialized and customizable testing solutions tailored to complex and rare conditions. Unlike commercial in vitro diagnostic (IVD) tests, which require regulatory approvals before reaching the market, LDTs are developed and validated within individual laboratories, allowing for rapid adaptation to emerging medical needs. This flexibility has made LDTs instrumental in personalized medicine, oncology, infectious disease detection, and genetic screening. As the demand for early and precise diagnostics continues to rise, LDTs are playing an increasingly vital role in bridging the gap between medical advancements and patient care.

One of the key factors driving the adoption of LDTs is their ability to address niche diagnostic needs that may not be met by commercially available tests. In oncology, for instance, LDTs are widely used for tumor profiling, enabling oncologists to tailor treatment strategies based on genetic mutations specific to individual patients. The rapid advancement of genomic sequencing technologies has further strengthened the relevance of LDTs, allowing for the identification of hereditary conditions, pharmacogenomic responses, and rare genetic disorders. Additionally, the COVID-19 pandemic underscored the importance of LDTs in responding swiftly to novel pathogens, as many laboratories developed their own testing methodologies before commercial kits were widely available.

How Are Technological Innovations Enhancing the Capabilities of LDTs?

The evolution of laboratory developed tests has been closely linked to advancements in molecular biology, artificial intelligence (AI), and automation. Next-generation sequencing (NGS) and polymerase chain reaction (PCR)-based techniques have significantly improved the accuracy and speed of LDTs, enabling the detection of minute genetic variations associated with disease susceptibility and progression. AI-driven bioinformatics tools have further refined the analytical capabilities of LDTs, allowing for real-time data interpretation and pattern recognition in large genomic datasets. These technological breakthroughs have expanded the scope of LDT applications, from oncology and rare disease diagnostics to infectious disease surveillance and reproductive health.

Automation has also played a pivotal role in the standardization and scalability of LDTs. High-throughput robotic systems now facilitate the processing of complex assays with minimal human intervention, reducing the risk of errors and increasing laboratory efficiency. The integration of cloud-based data storage and digital health platforms has enhanced accessibility, enabling healthcare providers to remotely access and analyze test results for more informed clinical decision-making. Moreover, advancements in liquid biopsy technology have paved the way for non-invasive LDTs, allowing for early cancer detection and monitoring through blood samples instead of traditional tissue biopsies. These innovations are driving greater adoption of LDTs across diverse healthcare settings, reinforcing their significance in precision medicine.

Are Regulatory Shifts Reshaping the Laboratory Developed Tests Market?

While LDTs have traditionally operated under a more flexible regulatory framework compared to commercially manufactured tests, recent regulatory shifts are poised to impact their development and adoption. In the United States, the Food and Drug Administration (FDA) has been considering increased oversight of LDTs to ensure test accuracy, reliability, and patient safety. This has sparked ongoing debates between regulatory agencies, diagnostic laboratories, and healthcare stakeholders regarding the balance between innovation and quality control. While stricter regulations may impose additional compliance burdens on laboratories, they also have the potential to enhance standardization and transparency, fostering greater trust in LDT-based diagnostics.

Global regulatory landscapes are also evolving, with countries like the European Union implementing the In Vitro Diagnostic Regulation (IVDR) framework, which affects LDTs and imposes more rigorous validation requirements. These changes have prompted many laboratories to invest in quality management systems, accreditation processes, and clinical validation studies to align with evolving regulatory standards. Despite these challenges, the demand for LDTs remains strong, particularly in regions where regulatory flexibility allows for rapid adaptation to emerging medical conditions. As regulatory agencies refine their approach to LDT oversight, laboratories will need to navigate compliance requirements while maintaining their ability to innovate and deliver high-value diagnostic solutions.

What Are the Key Growth Drivers Fueling the Laboratory Developed Tests Market?

The growth in the laboratory developed tests market is driven by several factors, including the increasing prevalence of complex diseases, advancements in diagnostic technologies, rising demand for personalized medicine, and evolving healthcare policies. One of the primary drivers is the growing burden of cancer, cardiovascular diseases, and genetic disorders, which require highly specific and sensitive diagnostic tests. LDTs offer the flexibility to develop targeted assays for early disease detection, treatment monitoring, and risk assessment, making them invaluable in precision medicine initiatives. As healthcare systems shift toward proactive and preventive care models, the demand for LDTs continues to rise.

Another major factor driving market growth is the expansion of genomic and molecular testing. The declining cost of genomic sequencing has made advanced LDTs more accessible, allowing for widespread adoption in clinical and research settings. The rise of companion diagnostics, which help determine the most effective treatments for individual patients, has further fueled LDT adoption in oncology and pharmacogenomics. Additionally, the increasing integration of AI and machine learning into laboratory workflows has improved the efficiency and accuracy of LDTs, driving confidence among healthcare providers and patients.

The growing emphasis on decentralized and point-of-care testing has also contributed to the expansion of LDTs, particularly in response to the COVID-19 pandemic. Many diagnostic laboratories developed their own rapid testing solutions to meet urgent public health demands, highlighting the agility of LDTs in crisis situations. Furthermore, the expansion of telemedicine and digital health platforms has increased the demand for remote and home-based diagnostic solutions, where LDTs play a crucial role in providing timely and accessible testing options.

Despite regulatory uncertainties, the laboratory developed tests market is expected to experience sustained growth as demand for specialized diagnostics continues to rise. The ongoing investments in precision medicine, coupled with advancements in biomarker discovery and high-throughput sequencing, will further drive innovation in LDTs. As laboratories navigate the evolving regulatory landscape, collaborations between research institutions, healthcare providers, and technology companies will be key in ensuring that LDTs remain a critical component of modern diagnostic medicine.

SCOPE OF STUDY:

The report analyzes the Laboratory Developed Tests market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology, Other Technologies); Application (Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application, Other Diseases Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• 23andMe, Inc.
• Abbott
• Agilent Technologies Inc.
• ARUP Laboratories
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• Guardant Health
• Illumina, Inc.
• Invitae Corporation
• Labcorp
• Mayo Clinic Laboratories
• Myriad Genetics, Inc.
• Natera, Inc.
• NeoGenomics Laboratories
• OPKO Health, Inc.
• QIAGEN
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sonic Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Laboratory Developed Tests - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increased Demand for Personalized Medicine Drives Growth in Laboratory Developed Tests
  • Advances in Genomics and Molecular Biology Propel Innovation in LDTs
  • Expansion of Precision Medicine Initiatives Strengthens the Business Case for LDTs
  • Growing Incidence of Chronic Diseases Accelerates Demand for LDTs
  • Shifting Focus Toward Early Diagnosis Spurs Market Growth for Laboratory Developed Tests
  • Increase in Research and Development Activities Enhances LDT Technology and Performance
  • Regulatory Clarity and Evolving Policies on LDTs Enhance Market Dynamics
  • Rising Adoption of Point-of-Care Diagnostics Expands Addressable Market for LDTs
  • Integration of Artificial Intelligence and Machine Learning in LDTs Drives Technological Advancements
  • Rising Awareness of the Benefits of LDTs Over Traditional Testing Methods Boosts Adoption
  • Growth in Academic and Clinical Research to Develop Novel LDTs Stimulates Market Opportunities
  • Patient-Centric Trends and the Shift Toward At-Home Testing Create New Demand for LDTs
  • Reimbursement Expansion for LDTs Accelerates Their Utilization in Healthcare Settings
  • Demand for Rapid, Accurate, and Cost-Effective Diagnostics Drives Growth in LDT Market
  • Regulatory Scrutiny and FDA Oversight on LDTs Shapes Market Development and Innovation
  • Technological Advancements in LDT Platforms Facilitate Faster Test Turnaround and Improve Accuracy
  • Increasing Number of Diagnostic Laboratories and Testing Centers Stimulates LDT Adoption
  • Expanding Healthcare Infrastructure in Emerging Markets Presents Growth Opportunities for LDTs
  • Rising Focus on Infectious Disease Testing Drives Demand for Specialized LDTs
  • Rising Investment and Funding for LDT Startups Spur Innovations in Test Development
  • Greater Collaboration Between Healthcare Providers and LDT Manufacturers Strengthens Market Outlook
  • Regulatory Push for Standardization and Quality Assurance in LDTs Drives Market Stability
  • Integration of Next-Generation Sequencing (NGS) in LDTs Expands Diagnostic Capabilities
  • Increased Global Healthcare Awareness and Education on LDTs Propels Demand
  • Expansion of Biotech and Pharmaceutical Industry Support for LDTs Fuels Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Laboratory Developed Tests Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Laboratory Developed Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Laboratory Developed Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Laboratory Developed Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Hematology & Coagulation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Hematology & Coagulation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Hematology & Coagulation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Histology / Cytology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Histology / Cytology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Histology / Cytology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Flow Cytometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Mass Spectroscopy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Mass Spectroscopy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Mass Spectroscopy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Genetic Disorders / Inherited Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Genetic Disorders / Inherited Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Genetic Disorders / Inherited Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Infectious & Parasitic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Infectious & Parasitic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Infectious & Parasitic Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Immunology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Immunology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Immunology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Endocrine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Nutritional & Metabolic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Nutritional & Metabolic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Nutritional & Metabolic Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Cardiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Mental / Behavioral Disorder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Mental / Behavioral Disorder Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Mental / Behavioral Disorder Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Pediatrics-specific Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Pediatrics-specific Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Pediatrics-specific Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Hematology / General Blood Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Hematology / General Blood Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Hematology / General Blood Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Bodily Fluid Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Bodily Fluid Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Bodily Fluid Analysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Toxicology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Toxicology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: World 15-Year Perspective for Toxicology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 68: World Recent Past, Current & Future Analysis for Other Diseases Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: World Historic Review for Other Diseases Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: World 15-Year Perspective for Other Diseases Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 71: USA Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: USA 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• CHINA
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 89: China Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Laboratory Developed Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Laboratory Developed Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Laboratory Developed Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Developed Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Laboratory Developed Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Laboratory Developed Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• INDIA
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: South Korea 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Asia-Pacific Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Asia-Pacific 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 179: Latin America Recent Past, Current & Future Analysis for Laboratory Developed Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 180: Latin America Historic Review for Laboratory Developed Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Latin America 15-Year Perspective for Laboratory Developed Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 182: Latin America Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Latin America Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Latin America 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Latin America 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 188: Argentina Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Argentina Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Argentina 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 191: Argentina Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Argentina Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Argentina 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 194: Brazil Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Brazil Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Brazil 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 197: Brazil Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Brazil Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Brazil 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 200: Mexico Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Mexico Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Mexico 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 203: Mexico Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Mexico Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Mexico 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 206: Rest of Latin America Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Latin America Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Latin America 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 209: Rest of Latin America Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Latin America Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Latin America 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 212: Middle East Recent Past, Current & Future Analysis for Laboratory Developed Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 213: Middle East Historic Review for Laboratory Developed Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Middle East 15-Year Perspective for Laboratory Developed Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 215: Middle East Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Middle East Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Middle East 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 218: Middle East Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Middle East Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Middle East 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 221: Iran Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Iran Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Iran 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 224: Iran Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Iran Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Iran 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 227: Israel Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Israel Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Israel 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 230: Israel Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Israel Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Israel 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 233: Saudi Arabia Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Saudi Arabia Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Saudi Arabia 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 236: Saudi Arabia Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Saudi Arabia Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Saudi Arabia 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 239: UAE Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: UAE Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: UAE 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 242: UAE Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: UAE Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: UAE 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 245: Rest of Middle East Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Middle East Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Middle East 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Middle East Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Middle East Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Middle East 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Laboratory Developed Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 251: Africa Recent Past, Current & Future Analysis for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Africa Historic Review for Laboratory Developed Tests by Technology - Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Africa 15-Year Perspective for Laboratory Developed Tests by Technology - Percentage Breakdown of Value Sales for Immunoassays Technology, Hematology & Coagulation Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Histology / Cytology Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 254: Africa Recent Past, Current & Future Analysis for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Africa Historic Review for Laboratory Developed Tests by Application - Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Africa 15-Year Perspective for Laboratory Developed Tests by Application - Percentage Breakdown of Value Sales for Oncology Application, Genetic Disorders / Inherited Disease Application, Infectious & Parasitic Diseases Application, Immunology Application, Endocrine Application, Nutritional & Metabolic Disease Application, Cardiology Application, Mental / Behavioral Disorder Application, Pediatrics-specific Testing Application, Hematology / General Blood Testing Application, Bodily Fluid Analysis Application, Toxicology Application and Other Diseases Applications for the Years 2015, 2025 & 2030

IV. COMPETITION